We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+17.12%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.13B
AUM Growth
+$460M
Cap. Flow
+$219M
Cap. Flow %
10.3%
Top 10 Hldgs %
40.03%
Holding
90
New
27
Increased
17
Reduced
15
Closed
3

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$32.8M
2
ZBH icon
Zimmer Biomet
ZBH
+$23.4M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$19.8M
4
DXCM icon
DexCom
DXCM
+$19.6M
5
WST icon
West Pharmaceutical
WST
+$18.9M

Top Sells

Rank Stock Value
1
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$41.2M
2
INBX
Inhibrx, Inc. Common Stock
INBX
+$17.9M
3
DAWN
Day One Biopharmaceuticals
DAWN
+$14.2M
4
ROIV icon
Roivant Sciences
ROIV
+$13.6M
5
SANA icon
Sana Biotechnology
SANA
+$9.05M

Sector Composition

Rank Sector Weight
1 Healthcare 90.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRAX icon
26
Praxis Precision Medicines
PRAX
$8.64B
$29.1M 1.37%
477,605
-178,943
-27% -$8.03M
MOH icon
27
Molina Healthcare
MOH
$9.99B
$28.8M 1.35%
70,088
– –
ELV icon
28
Elevance Health
ELV
$82B
$28.6M 1.35%
55,250
+7,569
+16% +$3.76M
IQV icon
29
IQVIA
IQV
$37.6B
$28.3M 1.33%
111,854
– –
VEEV icon
30
Veeva Systems
VEEV
$34.4B
$27.5M 1.3%
118,905
– –
EPIX
31
DELISTED
ESSA Pharma
EPIX
$25.3M 1.19%
2,980,420
-282,080
-9% -$2.46M
FXI icon
32
CALL
iShares China Large-Cap ETF
FXI
$4.33B
$24.6M 1.16%
+1,022,800
New +$23.6M
HCA icon
33
CALL
HCA Healthcare
HCA
$86.8B
$23.9M 1.13%
+71,800
New +$21.9M
DXCM icon
34
DexCom
DXCM
$32.8B
$21.6M 1.02%
+155,878
New +$19.6M
ACHC icon
35
Acadia Healthcare
ACHC
$2.95B
$21.2M 1%
267,734
-40,203
-13% -$3.29M
ACLX
36
DELISTED
Arcellx
ACLX
$21.1M 0.99%
303,210
-31,988
-10% -$2.03M
IWM icon
37
iShares Russell 2000 ETF
IWM
$83B
$20.8M 0.98%
+99,115
New +$19.8M
WST icon
38
West Pharmaceutical
WST
$24.5B
$20.3M 0.95%
+51,197
New +$18.9M
SYK icon
39
Stryker
SYK
$129B
$19.7M 0.93%
55,092
-3,537
-6% -$1.19M
HOWL icon
40
Werewolf Therapeutics
HOWL
$20.1M
$19.5M 0.92%
3,006,734
-461,443
-13% -$2.69M
IWM icon
41
CALL
iShares Russell 2000 ETF
IWM
$83B
$18.6M 0.88%
+88,600
New +$17.7M
ADAP
42
DELISTED
Adaptimmune Therapeutics
ADAP
$16.5M 0.77%
10,423,135
– –
SNDX icon
43
Syndax Pharmaceuticals
SNDX
$1.69B
$15.7M 0.74%
658,694
+63,171
+11% +$1.41M
IMVT icon
44
Immunovant
IMVT
$8.08B
$15.3M 0.72%
472,540
– –
MGX icon
45
Metagenomi Therapeutics
MGX
$45.6M
$13.4M 0.63%
+1,267,002
New +$14.6M
WAT icon
46
Waters Corp
WAT
$38.9B
$13.2M 0.62%
+38,464
New +$12.6M
OSCR icon
47
Oscar Health
OSCR
$9.16B
$12.8M 0.6%
860,821
+524,655
+156% +$7.19M
ARKK icon
48
ARK Innovation ETF
ARKK
$6.09B
$12.1M 0.57%
+242,260
New +$11.8M
BSX icon
49
Boston Scientific
BSX
$71.1B
$11.8M 0.56%
172,786
-65,350
-27% -$4.2M
ALKS icon
50
Alkermes
ALKS
$8.33B
$11.6M 0.55%
+429,573
New +$12.2M
1
2
3 4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return

PFM Health Sciences's Q1 2024 Portfolio in Review

As of Q1 2024, PFM Health Sciences held 90 positions worth $2.13B, up 28% from $1.67B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

PFM Health Sciences deployed $219M of net new capital in Q1 2024, opening 27 new positions and adding to 17 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 99,115 shares worth $20.8M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 97% a quarter earlier.

On the sell side, the largest reduction was Inhibrx, Inc. Common Stock, an estimated $17.9M trimmed.

  • PFM Health Sciences's largest Q1 2024 buy was iShares Russell 2000 ETF: 99,115 shares worth $20.8M.
  • PFM Health Sciences added most to Intuitive Surgical in Q1 2024, an estimated $32.8M increase.
  • PFM Health Sciences's biggest Q1 2024 reduction was Inhibrx, Inc. Common Stock, cutting an estimated $17.9M.
  • PFM Health Sciences fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $41.2M.
  • PFM Health Sciences's ten largest holdings make up 40% of its $2.13B portfolio in Q1 2024.
  • PFM Health Sciences opened 27 new positions and closed 3 in Q1 2024.
  • PFM Health Sciences's portfolio value rose 28% quarter-over-quarter to $2.13B.

Based on PFM Health Sciences's 13F filing for Q1 2024, filed 14 May 2024.